Keyhole surgery in the womb could fix spina bifida with fewer risks

NCT ID NCT03090633

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a minimally invasive fetoscopic surgery to repair spina bifida in unborn babies. The goal is to close the spinal defect and reverse brain herniation while reducing risks like uterine rupture and preterm birth that come with open fetal surgery. Thirty pregnant women with isolated spina bifida will be enrolled to see if this approach is both feasible and safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fetoscopic surgery (minimally invasive in-utero procedure using specialized endoscopes and instruments)
What this could lead to
If successful, this could offer a safer way to repair spina bifida before birth, reducing complications like uterine rupture and preterm birth, and possibly allowing vaginal delivery.
What could go wrong
This is a small, early feasibility study with only 30 participants. The procedure may not be as effective as open surgery, and risks like premature rupture of membranes or preterm labor remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIARI MALFORMATION TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins Hospital

    Baltimore, Maryland, 21202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.